151 related articles for article (PubMed ID: 30658151)
1. 2-(2,5-Dimethoxy-4-methylphenyl)-N-(2-methoxybenzyl)ethanamine (25D-NBOMe) and N-(2-methoxybenzyl)-2,5-dimethoxy-4-chlorophenethylamine (25C-NBOMe) induce adverse cardiac effects in vitro and in vivo.
Yoon KS; Yun J; Kim YH; Shin J; Kim SJ; Seo JW; Hyun SA; Suh SK; Cha HJ
Toxicol Lett; 2019 Apr; 304():50-57. PubMed ID: 30658151
[TBL] [Abstract][Full Text] [Related]
2. 2-((2-(4-Iodo-2,5-dimethoxyphenyl)ethylamino)methyl)phenol (25I-NBOH) and 2-(((2-(4-chloro-2,5-dimethoxyphenyl)ethyl)amino)methyl)phenol (25C-NBOH) induce adverse effects on the cardiovascular system.
Yoon KS; Cha HJ; Choi SO; Lee JM
Toxicol Lett; 2022 Feb; 355():160-169. PubMed ID: 34843874
[TBL] [Abstract][Full Text] [Related]
3. 25I-NBOMe, a phenethylamine derivative, induces adverse cardiovascular effects in rodents: possible involvement of p21 (CDC42/RAC)-activated kinase 1.
Yoon KS; Gu SM; Cha HJ; Kim YH; Yun J; Lee JM
Drug Chem Toxicol; 2022 Mar; 45(2):898-906. PubMed ID: 32597268
[TBL] [Abstract][Full Text] [Related]
4. Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: High potency agonists at 5-HT
Eshleman AJ; Wolfrum KM; Reed JF; Kim SO; Johnson RA; Janowsky A
Biochem Pharmacol; 2018 Dec; 158():27-34. PubMed ID: 30261175
[TBL] [Abstract][Full Text] [Related]
5. Cardiotoxic effects of [3-[2-(diethylamino)ethyl]-1H-indol-4-yl] acetate and 3-[2-[ethyl(methyl)amino]ethyl]-1H-indol-4-ol.
Yoon KS; Lee JM; Kim YH; Suh SK; Cha HJ
Toxicol Lett; 2020 Feb; 319():40-48. PubMed ID: 31706004
[TBL] [Abstract][Full Text] [Related]
6. Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and Other Dimethoxyphenyl-N-[(2-Methoxyphenyl) Methyl]Ethanamine Derivatives on Blotter Paper.
Poklis JL; Raso SA; Alford KN; Poklis A; Peace MR
J Anal Toxicol; 2015 Oct; 39(8):617-23. PubMed ID: 26378135
[TBL] [Abstract][Full Text] [Related]
7. Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents.
Gatch MB; Dolan SB; Forster MJ
Behav Pharmacol; 2017 Aug; 28(5):375-385. PubMed ID: 28537942
[TBL] [Abstract][Full Text] [Related]
8. Metabolic fate and detectability of the new psychoactive substances 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25B-NBOMe) and 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25C-NBOMe) in human and rat urine by GC-MS, LC-MS
Caspar AT; Brandt SD; Stoever AE; Meyer MR; Maurer HH
J Pharm Biomed Anal; 2017 Feb; 134():158-169. PubMed ID: 27915193
[TBL] [Abstract][Full Text] [Related]
9. Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats.
Elmore JS; Decker AM; Sulima A; Rice KC; Partilla JS; Blough BE; Baumann MH
Neuropharmacology; 2018 Nov; 142():240-250. PubMed ID: 29501528
[TBL] [Abstract][Full Text] [Related]
10. Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs).
Rickli A; Luethi D; Reinisch J; Buchy D; Hoener MC; Liechti ME
Neuropharmacology; 2015 Dec; 99():546-53. PubMed ID: 26318099
[TBL] [Abstract][Full Text] [Related]
11. 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing.
Stellpflug SJ; Kealey SE; Hegarty CB; Janis GC
J Med Toxicol; 2014 Mar; 10(1):45-50. PubMed ID: 23872917
[TBL] [Abstract][Full Text] [Related]
12. Designer Drug, 25D-NBOMe, Has Reinforcing and Rewarding Effects through Change of a Dopaminergic Neurochemical System.
Lee JG; Hur KH; Hwang SB; Lee S; Lee SY; Jang CG
ACS Chem Neurosci; 2023 Aug; 14(15):2658-2666. PubMed ID: 37463338
[TBL] [Abstract][Full Text] [Related]
13. Detection of 25C-NBOMe in Three Related Cases.
Kristofic JJ; Chmiel JD; Jackson GF; Vorce SP; Holler JM; Robinson SL; Bosy TZ
J Anal Toxicol; 2016 Jul; 40(6):466-72. PubMed ID: 27206645
[TBL] [Abstract][Full Text] [Related]
14. Methoxetamine Induces Cytotoxicity in H9c2 Cells: Possible Role of p21 Protein (Cdc42/Rac)-Activated Kinase 1.
Yoon KS; Gu SM; Lamichhane S; Han KM; Shin J; Kim YH; Suh SK; Cha HJ; Yun J
Cardiovasc Toxicol; 2019 Jun; 19(3):229-236. PubMed ID: 30377924
[TBL] [Abstract][Full Text] [Related]
15. P21 (Cdc42/Rac)-activated kinase 1 (pak1) is associated with cardiotoxicity induced by antihistamines.
Yun J; Kim SY; Yoon KS; Shin H; Jeong HS; Chung H; Kim YH; Shin J; Cha HJ; Han KM; Hyeon S; Lee TH; Park HK; Kim HS
Arch Pharm Res; 2016 Dec; 39(12):1644-1652. PubMed ID: 27681411
[TBL] [Abstract][Full Text] [Related]
16. 25C-NBOMe, a Novel Designer Psychedelic, Induces Neurotoxicity 50 Times More Potent Than Methamphetamine In Vitro.
Xu P; Qiu Q; Li H; Yan S; Yang M; Naman CB; Wang Y; Zhou W; Shen H; Cui W
Neurotox Res; 2019 May; 35(4):993-998. PubMed ID: 30806983
[TBL] [Abstract][Full Text] [Related]
17. Zebrafish and
Álvarez-Alarcón N; Osorio-Méndez JJ; Ayala-Fajardo A; Garzón-Méndez WF; Garavito-Aguilar ZV
Toxicol Rep; 2021; 8():315-323. PubMed ID: 33598409
[TBL] [Abstract][Full Text] [Related]
18. Application of a Urine and Hair Validated LC-MS-MS Method to Determine the Effect of Hair Color on the Incorporation of 25B-NBOMe, 25C-NBOMe and 25I-NBOMe into Hair in the Rat.
Nisbet LA; Venson R; Wylie FM; Scott KS
J Anal Toxicol; 2017 Jul; 41(6):559-565. PubMed ID: 28830123
[TBL] [Abstract][Full Text] [Related]
19. Schedules of Controlled Substances: Extension of Temporary Placement of Three Synthetic Phenethylamines in Schedule I. Final order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2015 Nov; 80(219):70657-9. PubMed ID: 26567439
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of use and acute toxicity associated with the use of NBOMe drugs.
Wood DM; Sedefov R; Cunningham A; Dargan PI
Clin Toxicol (Phila); 2015 Feb; 53(2):85-92. PubMed ID: 25658166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
